groups at the chiral center seem to suggest some degree of
coordination of the ligand-free cationic palladium intermedi-
ate to the potentially coordinating groups at C-5.9
catalytic hydrogenation to give a ∼1:1 mixture of Boc-5-
phenylprolines 9a,b, which were deprotected with HCl/
MeOH to give the diastereomeric phenylproline methyl esters
in an overall yield of 48%. Flash chromatography provided
the two diastereomers 10a and 10b in pure form. Overall,
the desired (2S,5R)-phenylproline methyl ester 10b was
obtained in three steps with an overall yield of 26% from
enecarbamate 7.11
Despite the present low stereoselectivity, a quick access
to 2,5-cis aryl prolinols and prolines (entries 7, 8, and 12)
by these Heck arylations opens new routes to synthetically
relevant intermediates that are otherwise difficult to prepare.
In the specific case of arylation of endocyclic enecarbam-
ate 7, this opens the way to the synthesis of (2S,5R)-phenyl
proline methyl ester, a known precursor of the nonpeptide
cholecystokinin antagonist (+)-RP 66803 3 in a very concise
manner.10 A straightforward synthesis of the (2S,5R)-
phenylproline methyl ester is presented in Scheme 1. Heck
Another illustrative application of the cis Heck adduct
obtained from the arylation of the hydroxy enecarbamate 5
was the total synthesis of the antiprotozoan C-azanucleo-
side 4. Protozoan parasite infections such as malaria and
trypanosomiasis are among the most important tropical
diseases, causing a heavy toll in lives and productivity in
developing and underdeveloped countries.12 A key charac-
teristic of these parasites is the lack of a de novo pathway
for purine biosynthesis, and as a result, these organisms need
to salvage purines from the host for the synthesis of their
own DNA and RNA.13 For this purpose, the parasites produce
a family of nucleoside N-ribosyl hydrolases that are not found
in mammalian cells, thus making the N-ribosyl hydrolases
suitable targets for inhibition and creating viable therapeutic
control of the disease.14
Scheme 1. Synthesis of the (2S,5R), and (2S,5S)-Phenyl
Proline Methyl Esters from Enecarbamate 7
Recently, Schramm and Tyler reported on 1-arylimino-
ribitols, which bind tightly to nonspecific nucleoside hydro-
lases such as inosine-uridine nucleoside hydrolase (IU-NH)
and to specific nucleoside hydrolases such as the inosine-
adenosine-guanosine nucleoside hydrolase (IAG-NH).15 The
trypanosomal nucleoside hydrolase IU-NH involved in purine
salvage pathways is strongly inhibited by the p-amino-
phenyliminoribitol 4 with a dissociation constant of 30 nM.16
(a) C6H4N2BF4, Pd2dba3 (4 mol %), NaOAc, MeCN, 30 °C, 30
min (85%). (b) H2, 10%-Pd/C, 15 h, rt (100%). (c) HCl/MeOH,
rt, 1 h (61%).
Heck arylation of prolinol enecarbamate 5 provided a new
and concise route to the synthesis of Schramm’s C-
azanucleoside 4. The first stage involved the preparation of
the hydroxy enecarbamate 5 from the silyloxy enecarbamate
11 with TBAF (Scheme 2). Heck arylation of the hydroxy
arylation of enecarbamate 7 using phenyldiazonium tetra-
fluoroborate required 4 mol % Pd2(dba)3 and a reaction
temperature of ∼30 °C to attain good yields of the Heck
adducts. The arylation proceeded with an unexpected low
stereoselectivity (compare with entries 9-11, Table 1)
providing a 45:55 (trans/cis) inseparable mixture of 5-phenyl
dehydroprolines 8a/8b, indicating a further dependence of
the stereoselectivity on the diazonium salt substitution
pattern. The mixture of 3,4-dehydroprolines underwent
Scheme 2. Synthesis of the Arylpyrroline Precursor of
Schramm’s C-Azanucleoside
(9) There are many precedents for the stereocontrolled Heck arylation
of olefins promoted by proximal functional groups. For some representative
examples, see: (a) Olofsson, K.; Sahlin, H.; Larhed, M.; Hallberg, A. J.
Org. Chem. 2001, 66, 544. (b) Nilsson, P.; Larhed, M.; Hallberg, A. J. Am.
Chem. Soc. 2001, 123, 8217. (c) Olofsson, K.; Larhed, M.; Hallberg, A. J.
Org. Chem. 2000, 65, 7235. (d) Itami, K.; Mitsudo, K.; Kamei, T.; Koike,
T.; Nokami, T.; Yoshida, J. J. Am. Chem. Soc. 2000, 122, 12013. (e) Buezo,
N. D.; Alonso, I.; Carretero, J. C. J. Am. Chem. Soc. 1998, 120, 7129. (f)
Kang, S.-K.; Lee, H.-W.; Jang, S.-B.; K. T.-H.; Pyun, S.-J. J. Org. Chem.
1996, 61, 2604. (g) Madin, A.; Overman, L. Tetrahedron Lett. 1992, 33,
4859.
(10) Previous synthesis of the (2S,5R)-phenylproline methyl ester: (a)
ref 5. (b) Haddad, M.; Imogai, H.; Larcheveˆque, M. J. Org. Chem. 1998,
63, 5680. (c) Davis, F. A.; Fang, T.; Goswami, R. Org. Lett. 2002, 4, 1599.
(d) Momotake, A.; Togo, H.; Yokoyama, M. J. Chem. Soc., Perkin Trans.
1 1999, 1193. (e) Betsbrugge, J. V.; Nest, W. V. D.; Verheyden, P.; Tourwe´,
D. Tetrahedron 1998, 54, 1753. (f) Zaluski, M. C. F.; Coric, P.; Thery, V.;
Gonzalez, W.; Meudal, H.; Turcaud, S.; Michel, J. B.; Roques, B. P. J.
Med. Chem. 1996, 39, 2594.
(a) TBAF 1M, THF, 0 °C, 1 h (93%); (b) Pd2(dba)3‚dba (1 mol
%), MeCN, NaOAc, 30 min, rt (80%); (c) chromatographic
separation.
enecarbamate 5 gave the Heck adducts with a modest
stereoselectivity in favor of the cis adduct in good yield (80%
yield; 60:40 diastereomeric ratio).
Org. Lett., Vol. 5, No. 3, 2003
307